^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
Source:
Title:

Identification of Genotype-Specific Therapeutic Vulnerabilities By Comparative Dynamic BH3 Profiling Analysis of Human and Murine CLL

Published date:
11/06/2019
Excerpt:
...7 BCR signaling inhibitors (BCRi, including PI3K inhibitors idelalisib, duvelisib, umbralisib...Notably, Sf3b1mut/Atmdel CLL cells were more resistant to the panel of BCRi than MDR cells (p=0.046, the Van Elteren test) and their dependence on BCL-2 for survival after BCRi was likewise diminished (p=0.018, the Van Elteren test…
DOI:
https://doi.org/10.1182/blood-2019-127293